pCDNA3.1(+)-CMV-bArrestin2-TEV Citations (3)

Originally described in: PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.
Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguere PM, Sciaky N, Roth BL Nat Struct Mol Biol. 2015 May;22(5):362-9. doi: 10.1038/nsmb.3014. Epub 2015 Apr 20. PubMed Journal

---

Articles Citing pCDNA3.1(+)-CMV-bArrestin2-TEV

Articles
Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant Peptides. Lieb A, Thaler G, Fogli B, Trovato O, Posch MA, Kaserer T, Zangrandi L. Biomedicines. 2021 Dec 11;9(12). pii: biomedicines9121882. doi: 10.3390/biomedicines9121882. PubMed
Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses. Schulz R, Korkut-Demirbas M, Venturino A, Colombo G, Siegert S. Nat Commun. 2022 Aug 15;13(1):4728. doi: 10.1038/s41467-022-32390-1. PubMed
Dopamine receptor D2 confers colonization resistance via microbial metabolites. Scott SA, Fu J, Chang PV. Nature. 2024 Apr;628(8006):180-185. doi: 10.1038/s41586-024-07179-5. Epub 2024 Mar 13. PubMed

If you have published an article using this material, please email us at to have your article added to this page.